ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,511.40
-0.11%
S&P ASX All Technology
4,034.50
0.55%
Brent Oil
74.565
0.00%
US Dollar vs AUD
1.5949
0.00%
Bitcoin
96,437.97
-0.03%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Biogen Inc (0R1B) Share Price

Biogen Inc

Biogen Inc (0R1B)

LSE
277.67
0.00
(0.00%)
Closed 10 February 3:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
277.67
Bid
0.00
Offer
0.00
Volume
1,804
0.00 Day's Range 0.00
277.67 52 Week Range 277.67
Market Cap
40.234B
Previous Close
277.67
Open
-
Last Trade
7
@
141.04
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
4,712
Shares Outstanding
144,898,000
Dividend Yield
-
PE Ratio
17.64
Earnings Per Share (EPS)
8.01
Revenue
9.84B
Net Profit
1.16B

About Biogen Inc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.biogen.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0R1B. The last closing price for Biogen was US$277.67. Over the last year, Biogen shares have traded in a share price range of US$ 277.67 to US$ 277.67.

Biogen currently has 144,898,000 shares in issue. The market capitalisation of Biogen is US$40.23 billion. Biogen has a price to earnings ratio (PE ratio) of 17.64.

Ask ADVFN Intelligence (AI)

0R1B Latest News

More News

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union TOKYO and CAMBRIDGE, Mass., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo...

31 January 2025
UK Regulatory

FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Once every four weeks maintenance dosing may be easier for patients and care partners to...

27 January 2025
UK Regulatory

FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA

FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher...

23 January 2025
UK Regulatory

FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease LEQEMBI is the only FDA-approved anti-amyloid...

14 January 2025
UK Regulatory

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity Dapirolizumab pegol (DZP) met its...

19 November 2024
UK Regulatory

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd...

15 November 2024
UK Regulatory

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference -New testing method highlights link...

31 October 2024
UK Regulatory

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases The collaboration aims to...

30 October 2024
UK Regulatory

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as...

29 October 2024
UK Regulatory

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025 Robin Kramer, Chief Accounting Officer, to Succeed HimCAMBRIDGE, Mass., Oct. 28, 2024 (GLOBE...

28 October 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100277.67277.67277.672285277.67DE
400277.67277.67277.673858277.67DE
1200277.67277.67277.674712277.67DE
2600277.67277.67277.673740277.67DE
5200277.67277.67277.673528277.67DE
15600277.67277.67277.674673277.67DE
26000277.67277.67277.673995277.67DE

0R1B - Frequently Asked Questions (FAQ)

What is the current Biogen share price?
The current share price of Biogen is US$ 277.67
How many Biogen shares are in issue?
Biogen has 144,898,000 shares in issue
What is the market cap of Biogen?
The market capitalisation of Biogen is USD 40.23B
What is the 1 year trading range for Biogen share price?
Biogen has traded in the range of US$ 277.67 to US$ 277.67 during the past year
What is the PE ratio of Biogen?
The price to earnings ratio of Biogen is 17.64
What is the cash to sales ratio of Biogen?
The cash to sales ratio of Biogen is 2.08
What is the reporting currency for Biogen?
Biogen reports financial results in USD
What is the latest annual turnover for Biogen?
The latest annual turnover of Biogen is USD 9.84B
What is the latest annual profit for Biogen?
The latest annual profit of Biogen is USD 1.16B
What is the registered address of Biogen?
The registered address for Biogen is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, NEW CASTLE, WILMINGTON, DELAWARE, 19810
What is the Biogen website address?
The website address for Biogen is www.biogen.com
Which industry sector does Biogen operate in?
Biogen operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ASTAscent Resources Plc
1.90p
(100.00%)
591.55k
NTQEnteq Technologies Plc
2.85p
(58.33%)
17.97M
THRUThruvision Group Plc
3.25p
(30.00%)
307.66k
IMMImmupharma Plc
4.98p
(27.69%)
14.75M
GEXGeorgina Energy Plc
6.375p
(24.39%)
5.16M
BELLBelluscura Plc
1.875p
(-71.15%)
13.68M
APQApq Global Limited
2.00p
(-69.23%)
60.87k
IOMIomart Group Plc
45.40p
(-23.57%)
1.76M
SYMESupply@me Capital Plc
0.002p
(-20.00%)
736.23M
PRMProteome Sciences Plc
3.50p
(-17.45%)
50.06k
SYMESupply@me Capital Plc
0.002p
(-20.00%)
736.23M
ORCPOracle Power Plc
0.017p
(-14.14%)
523.64M
CPAICapai Plc
0.0475p
(7.95%)
355.25M
NTVONativo Resources Plc
0.0017p
(0.00%)
347.62M
MSMNMosman Oil And Gas Limited
0.04p
(2.56%)
263.67M

Discussion

View Full Feed
dinogreeves dinogreeves 2 minutes ago
Largest South Korean Pension Fund made a move on SMCI in the month of February.
SMCI
MoneyMike1 MoneyMike1 3 minutes ago
I asked Ward about it. He said he was as confused about what happened as we were. His thoughts are that someone from his inner circle may have sabotaged him, but he didn't know.
MRGE
Catpole Catpole 3 minutes ago
I would hope that whoever is making the presentation would break it down in more detail and stress the importance of a funding source such as a license agreement and/or partnership. Certainly, needs a more professional look along with someone making a sales presentation.
RSPI
MartinLutherKing MartinLutherKing 3 minutes ago
Buyout on radar screens🚀🚀🚀🚀🚀
FOXO
al44 al44 3 minutes ago
Kristi Noem: not all hat and no cattle

By Mike McDaniel


Noem’s visit to the border was more than political posturing. The agents with whom she rode know her promise to let them do their jobs and to give them what they need, like her, is real. Unlike Alejandro Ma
MartinLutherKing MartinLutherKing 3 minutes ago
Live the dream brother🚀🚀🚀🚀
https://www.nbcdfw.com/news/local/texas-news/openai-flagship-texas-data-center-new-locations/3763833/?amp=1
FOXO
dinogreeves dinogreeves 4 minutes ago
Two more trading sessions till we find out what this business update is about.
SMCI
redspinelpinktopaz redspinelpinktopaz 4 minutes ago
If the tier ones are lined up at the door, because they want to triple the speed, use less electricity, and have a smaller footprint, why do "We need to give Yves time to work his magic", as you say.
LWLG
thecrusher2011 thecrusher2011 5 minutes ago
The unbridled contempt for the liberal philosophy is growing by the day. Food for my soul the great awakening is happening.

https://investorshub.advfn.com/uimage/uploads/2025/2/9/ioeqzScreenshot_20250209-102041.png
Zardiw Zardiw 5 minutes ago
Got the 8KSpy Alert on $XNDA

8KSpy - XNDA,OTC,0.09,Current, ,100 - Changes in Control

14:34:03
Tribal Rides International Corp.

https://www.otcmarkets.com/stock/XNDA/disclosure

The company name shown at the top should match the name
XNDA
blackhawks blackhawks 6 minutes ago
I don't know how you construe 'amazed' from a post that drips with contempt and deserved sarcasm toward a simpleton who IS A sucker for conspiracy theories, pseudo-philosophy and 'intellectually dubious books'.
TKS PARTY TKS PARTY 6 minutes ago
Super Sunday, waiting on a Super Monday !!!! Just once wake up Monday morning with the Mabanaft deal in a major PR announcement that would jump start our stock to all-time highs. Instead, baseball season is about to start, and I'm reminded of the great Cal Ripken and his 2,632 consecutive game s
CBRF
DiscoverGold DiscoverGold 9 minutes ago
Gold CoT: Peek Into Future Through Futures, How Hedge Funds Are Positioned
By: Hedgopia | February 8, 2025

• Following futures positions of non-commercials are as of February 4, 2025.

Gold: Currently net long 302.5k, up 3.1k.

hedgopia.com/wp-c
GDX
Catpole Catpole 9 minutes ago
I thought the presentation was educational and helped me understand the basics of what is being studied. Now we just need a big license agreement on any one of the projects and off we go. I look forward to another update from this next presentation.
RSPI
Lime Time Lime Time 9 minutes ago
It's dated nonsense. No longer applies here. A new chapter is about to be opened. Nothing from the past is relevant.
GVSI
DiscoverGold DiscoverGold 9 minutes ago
NY Gold Futures - Pressing Higher »» Weekly Summary Analysis
By: Marty Armstrong | February 8, 2025

NY Gold Futures closed today at 28876 and is trading up about 9.33% for the year from last year's settlement of 26410. Currently, this market has been rising for this month
GDX
Jack_Bolander Jack_Bolander 10 minutes ago
My firm recently did a "State of the Industry" Client Study on Hydrogen, Here are some of our findings :

- Legacy Hydrogen ; Grey Hydrogen for the petrochemical sector, is the only commercially viable use of hydrogen at scale

- No on-road use of hydrogen has been financ
BLDP
Debunkinator Debunkinator 10 minutes ago
$ASII Revenue Guidance rescheduled for Tuesday, but the company is working on a new JV deal w a major telco to be announced in the coming days. #Telco #Blockchain #JV
ASII
fredscott36 fredscott36 11 minutes ago
......UBS/sergio p. ermotti is two mouse CLICKS away from ALL OF THE LIBOR DISASTER..........closed, finished and done with.......and not one guilty ANTITRUST verdict............UBS artfully weaseled out of every suit.........(only 1 UBS employee took the responsibility for the CRIMES - - tommy haye
UBS
Oh The Wise Guy Oh The Wise Guy 12 minutes ago
Shiba inu etherscan
Each and every transaction is recorded, you or anyone in the world can check for themselves the current circulating supply, and the amount that's been sent to the dead wallet (being burned) with the time date stamp and the amount of tokens transferred and the wallets they
SHIBUSD
Jack_Bolander Jack_Bolander 13 minutes ago
Banger - There are some heavily subsiduized examples of hydrogen viability , specifically South Korea.

But, without subsidies, only grey hydrogen for hydrotreating appears to be successful.
PLUG
al44 al44 13 minutes ago
Trump imposes sanity on a green EV market

By Mike McDaniel


Former Transportation Secretary Pete Buttigieg’s fecklessness is the stuff of legend. Given $7 billion to build a half million charging stations across American, in two years Buttigieg managed to build o
trading.jeff trading.jeff 13 minutes ago
Bottom line, indeed, and filings make it "official."
But checking for filings I could not find any. Bottom line is that Tony needs to apply for all necessary permits in Illinois. In doing so he has to put details of ownership.
$APRU
APRU
delerious1 delerious1 14 minutes ago
It's all here....https://investorshub.advfn.com/Hydrogen-Hub-43696....

Your Recent History

LSE
0R1B
Biogen
BIT
I09994
XS2792224664 20280428 14...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads